Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Accelerates Growth Of Federated Hermes Fhi Stock Price At 55.03 Down 0.43 20260328 Inn E Stock Analysis Summit Hotel 6.25Pct Series E Preferred Trades Flat At 100 Amid Stable Lodging Trends 20260403 Docu Stock Analysis Docusign Inc. Posts 1.6 Percent Daily Gain To Hold Steady Near 48 Dollar Level 20260401 1 Is Darden Dri Stock Reacting To Market Price At 187.87 Down 2.35 20260413 Is Nuveen Jce Stock Worth Buying Now Price At 14.92 Up 0.34 20260406 What Is The Sentiment Around Spire Global Spir Stock Price At 22.69 Up 5.24 20260413 Is Fst Kbsx Stock Safe To Buy Now Price At 1.35 Down 2.52 20260408 What Happens To Slide Slde Stock In Recession Price At 18.01 Down 0.50 20260409 Is Chanson Chsn Stock Trading Below Intrinsic Value Price At 2.53 Down 9.64 20260408 Waste WCN Stock Moving in Trend Touches Low 20260418 GGRP The Glimpse Group Inc reports wider Q1 2026 loss than expected shares fall 302 amid negative investor sentiment Nexxen International NEXN Stock Buy or Sell Smart Money Flows 20260415 BLD TopBuild Corp falls 317 after posting 18 Q4 2025 EPS miss against analyst consensus estimates Dave Inc DAVE What Lies Ahead Q4 2025 EPS Exceeds Expectations Trupanion TRUP Stock Why Intellectual Property Overhead Buying 20260418 ARRC ARMOUR Pfd C preferred stock declares quarterly results 7 dividend yield attracts income investors GNSS Genasys falls 683 percent after Q1 2026 EPS miss offsets strong 698 percent yearoveryear revenue growth How Goldman GSBD margins compare to industry leaders 178 20260511 What is the growth outlook for aTyr Pharma ATYR stock RangeBound 20260420 OGN Organon shares rise 339 percent despite Q4 2025 earnings miss and 29 percent annual revenue drop National NHC Stock Investment Signals Touches Low 20260420 The key risks discussed in Primoris PRIM earnings Primoris Misses Estimates by 315 Vertex Pharmaceuticals VRTX Poised for Upside From Partner CRISPR Therapeutics 2026 Clinical Catalysts Toyota Motor Corporation TM Rising Gas Prices Drive US EV Interest Surge Affordability Remains Key Adoption Barrier Modular Medical MODD shares climb 33 percent despite wider Q3 loss as investors brush off earnings miss Is MFS MGF stock cyclical or defensive GNLB Global Net full quarterly earnings metrics and management guidance are still awaiting official public release IMMP Immutep Q1 2026 EPS falls short of estimates sparking a 201 percent share price dip in todays session The technology investments behind Disc Medicine IRON growth Q4 2025 EPS Exceeds Expectations NSTS Bancorp NSTS latest quarterly earnings update outlines managements priority of expanding regional community banking services How SELLAS SLS pricing offsets input costs Q4 2025 EPS Tops Views QGEN Qiagen falls 121 after Q4 2025 EPS narrowly misses Wall Street consensus estimates Fuse Group Holding Faces Persistent Challenges With Minimal Revenue and GoingConcern Uncertainty Creator Content Steals the Spotlight at TVs Upfronts Signaling a Shift in Advertiser Priorities Bill Ackmans Pershing Square Builds Microsoft Stake Citing Rare Valuation Opportunity in AI and Cloud Growth Beloved UK Car Model Poised for Electric Revival with Seven New European Models Elon Musk and Sam Altman From OpenAI CoFounders to Legal Rivals An 11Year Relationship Unravels Yen Faces Renewed Pressure as Markets Price in Potential Fed Rate Hike Trumps China Visit Revives Scrutiny Over Chip Exports and Rare Earths Strategy The9 NCTY Trading at 534 Key Decision Point 20260519 Halliburton Company HAL Stock Analysis Climbs 201 Eyes on 4473 20260518 Kevin Warshs Preferred Inflation Gauge Faces Scrutiny as Bank of America Warns of Potential Pitfalls Manhattan Associates MANH Delivers Q1 2026 Beat EPS 124 vs 114 Expected What Beta Bionics BBNXs 063 Decline Means for Investors 20260518 NFL Calls for Restrictions on Prediction Market Contracts to Protect Game Integrity Allegheny ATI Holds 16527 Direction Awaited 20260514 Arcadia Biosciences RKDA Delivers Q3 2025 Beat EPS 062 vs 055 Expected